By Kevin E. Noonan — As posted Monday, BIO (the Biotechnology Innovation Organization) provided a link to the supposed compromise agreement reached recently to permit WTO member states to waive patent protection for "subject matter required for the production and supply of COVID-19 vaccines without the consent of the right holder to the extent necessary to address the COVID-19 pandemic." The effects of such a waiver are being debated by those against it (mostly members of industry having vaccine-related IP protection and industries making vaccines) and in favor (NGOs, such as Médecins Sans Frontières) and, of course, the governments who…
